Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) have been assigned an average rating of “Hold” from the six analysts that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation on the company.
CZMWY has been the topic of several analyst reports. Sanford C. Bernstein lowered Carl Zeiss Meditec to a “market perform” rating in a report on Monday. The Goldman Sachs Group lowered shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th.
Read Our Latest Report on CZMWY
Carl Zeiss Meditec Stock Performance
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
